Why the study?
Do supplemental repair strategies like papillary muscle relocation improve the durability of mitral valve repair in patients with functional mitral regurgitation?
Do supplemental repair strategies like papillary muscle relocation improve the durability of mitral valve repair in patients with functional mitral regurgitation?
Answers are grounded in this paper and cite their sources.
The long-term durability of supplemental subannular repair strategies for functional mitral regurgitation remains uncertain, with ventricular size likely playing a critical role in determining repair success.
Central MessageSupplemental repair strategies for FMR, including papillary muscle relocation, are valuable adjuncts to downsizing annuloplasty; however, durability for different size ventricles remains in question.See Article page 92. Supplemental repair strategies for FMR, including papillary muscle relocation, are valuable adjuncts to downsizing annuloplasty; however, durability for different size ventricles remains in question. See Article page 92. In this review by Pausch and colleagues,1Pausch J. Girdauskas E. Conradi L. Reichenspurner H. Secondary mitral regurgitation repair techniques and outcomes: subannular repair techniques in secondary mitral regurgitation type IIIb.J Thorac Cardiovasc Surg Tech. 2021; 10: 92-97Scopus (2) Google Scholar supplemental repair techniques for functional mitral regurgitation (MR) are summarized. The authors tout papillary muscle relocation as a valid adjunct to downsizing annuloplasty, particularly with its immediate echocardiographic benefits in controlling leaflet tethering. However, as in the infamous nursery rhyme “London Bridge Is Falling Down,” we may be able to build the mitral complex up with “stone so strong will last so long”—but the question is how long? The 2016 randomized controlled clinical trial by Nappi and colleagues2Nappi F. Lusini M. Spadaccio C. Nenna A. Covino E. Acar C. et al.Papillary muscle approximation versus restrictive annuloplasty alone for severe ischemic mitral regurgitation.J Am Coll Cardiol. 2016; 67: 2334-2346Crossref PubMed Scopus (107) Google Scholar,3Nappi F. Spadaccio C. Chello M. Mihos C.G. Papillary muscle approximation in mitral valve repair for secondary MR.J Thorac Dis. 2017; 9: S635-S639Crossref PubMed Scopus (11) Google Scholar compared patients with severe ischemic mitral regurgitation (IMR) who underwent coronary artery bypass grafting revascularization with either combined papillary muscle approximation (PMA) and restrictive annuloplasty (RA) or undersized valve repair alone. Preoperative left ventricular end-diastolic diameter was 62.7 ± 3.4 mm in the PMA group and 61.4 ± 3.7 mm in the RA group. While PMA demonstrated significant improvement in left ventricular end-diastolic diameter during follow-up, there was no statistically significant difference in clinical outcomes. Importantly, this study observed a high rate of MR recurrence in both groups: 55.9% for RA and 27% for PMA. These findings beg the question: in which subset of patients with MR is papillary muscle relocation appropriate? The 2014 Cardiothoracic Surgical Trials Network trial randomly assigned patients with severe IMR to either repair or chordal-sparing replacement to evaluate efficacy and safety.4Acker M.A. Parides M.K. Perrault L.P. Moskowitz A.J. Gelijns A.C. Voisine P. et al.Mitral-valve repair versus replacement for severe ischemic mitral regurgitation.N Engl J Med. 2014; 370: 23-32Crossref PubMed Scopus (568) Google Scholar While there was no survival difference, ominously, at 2 years, the rate of recurrence of moderate or severe MR was 58.8% in the repair group (vs 3.8% in the replacement group, P < .001).5Goldstein D. Moskowitz A.J. Gelijns A.C. Ailawadi G. Parides M.K. Perrault L.P. et al.Two-year outcomes of surgical treatment of severe ischemic mitral regurgitation.N Engl J Med. 2016; 374: 344-353Crossref PubMed Scopus (485) Google Scholar A subset analysis by Capoulade and colleagues6Capoulade R. Zeng X. Overbey J.R. Ailawadi G. Alexander J.H. Ascheim D. et al.Impact of left ventricular to mitral valve ring mismatch on recurrent ischemic mitral regurgitation after ring annuloplasty.Circulation. 2016; 134: 1247-1256Crossref PubMed Scopus (43) Google Scholar of the 2 Cardiothoracic Surgical Trials Network trials on patients with IMR who received MV repair demonstrated that left ventricular end-systolic dimension was significantly greater in patients with recurrent MR (48 ± 8 vs 45 ± 9 mm; P = .01). In univariate analysis, patients with large ventricle size after MR were predicted to have 1-year recurrent MR after ring annuloplasty (odds ratio per 10-mm increase, 1.62; 95% confidence interval, 1.09-2.40; P = .02).6Capoulade R. Zeng X. Overbey J.R. Ailawadi G. Alexander J.H. Ascheim D. et al.Impact of left ventricular to mitral valve ring mismatch on recurrent ischemic mitral regurgitation after ring annuloplasty.Circulation. 2016; 134: 1247-1256Crossref PubMed Scopus (43) Google Scholar This re-echoes the data from Braun and reinforces that the LV ultimately holds the fate of the repaired valve.7Braun J. van de Veire N.R. Klautz R.J. Versteegh M.I. Holman E.R. Westenberg J.J. et al.Restrictive mitral annuloplasty cures ischemic mitral regurgitation and heart failure.Ann Thorac Surg. 2008; 85 (discussion 436-7): 430-436Abstract Full Text Full Text PDF PubMed Scopus (242) Google Scholar Which ventricles benefit from relocating the papillary muscles or performing other adjunct techniques to prevent recurrent MR is yet unknown. Whether functional mitral repair with subannular repair strategies is durable enough to “last so long, last so long,” only time will tell. Secondary mitral regurgitation repair techniques and outcomes: Subannular repair techniques in secondary mitral regurgitation type IIIbJTCVS TechniquesVol. 10PreviewFeature Editor's Note—Despite decades of experimental and clinical work, secondary mitral regurgitation is still a challenge for cardiac surgeons. The excellent outcomes achieved in the treatment of organic mitral disease are light years away for secondary mitral regurgitation. Treating secondary mitral disease is too often a humbling and frustrating experience for all the parties involved (most importantly the patients). We now know that techniques that were designed to treat valvular problems do not work well when the mechanism of the mitral regurgitation is within the left ventricle, but it is still unclear if mitral valve repair may or may not have a role in this setting.
No takes yet. Share an insight, caveat, or question.
James et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: